Andrew is a Clinical Research Fellow at the Department of Biochemistry University of Oxford. His role involves contributing to the design and delivery of malaria vaccine and immunology clinical trials as well as providing medical oversight of trial participants. Our studies often involve Controlled Human Malaria Infections (CHMIs) or "malaria challenges". After completing his medical training at the University of St Andrews and the University of Dundee, Andrew worked as a study doctor for COVID-19 vaccine clinical trials in Edinburgh, including the Oxford-AstraZeneca and Valneva vaccines. He has a keen interest in Infectious Diseases and has a Diploma in Tropical Medicine and Hygiene from the Liverpool School of Tropical Medicine.